P
Phenox
Dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of neurovascular diseases
About Phenox
Phenox, founded in 2005, specializes in developing innovative and clinically proven technologies for treating neurovascular diseases. The company serves endovascular specialists who treat ischemic and hemorrhagic strokes. Operating in the medical device market, Phenox offers a portfolio of advanced treatment options, including aneurysm implants and flow diverter coatings designed to reduce thrombosis risk. The business model revolves around the sale of these specialized medical devices, generating revenue through direct sales and partnerships. Phenox is committed to expanding its global reach, making its cutting-edge solutions accessible to more patients worldwide.
Source: Dealroom company dataNews
Knowledge graph
Open roles
Phenox in the Bochum ecosystem
The Phenox office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
See Phenox on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
